James J. Burns & Company LLC Boosts Holdings in Danaher Co. (NYSE:DHR)

James J. Burns & Company LLC grew its position in Danaher Co. (NYSE:DHR) by 6.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,796 shares of the conglomerate’s stock after acquiring an additional 106 shares during the quarter. James J. Burns & Company LLC’s holdings in Danaher were worth $499,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Greenwood Capital Associates LLC boosted its holdings in Danaher by 19.9% during the 3rd quarter. Greenwood Capital Associates LLC now owns 33,526 shares of the conglomerate’s stock valued at $9,321,000 after acquiring an additional 5,559 shares during the period. FSM Wealth Advisors LLC boosted its stake in shares of Danaher by 1.9% during the third quarter. FSM Wealth Advisors LLC now owns 5,829 shares of the conglomerate’s stock valued at $1,621,000 after purchasing an additional 108 shares during the period. Hazlett Burt & Watson Inc. grew its holdings in shares of Danaher by 544.6% in the third quarter. Hazlett Burt & Watson Inc. now owns 6,581 shares of the conglomerate’s stock worth $1,830,000 after purchasing an additional 5,560 shares during the last quarter. Quintet Private Bank Europe S.A. lifted its holdings in Danaher by 12.6% during the 3rd quarter. Quintet Private Bank Europe S.A. now owns 950 shares of the conglomerate’s stock valued at $264,000 after buying an additional 106 shares in the last quarter. Finally, PDS Planning Inc lifted its holdings in Danaher by 2.2% during the 3rd quarter. PDS Planning Inc now owns 3,628 shares of the conglomerate’s stock valued at $1,009,000 after buying an additional 78 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Insiders Place Their Bets

In other news, SVP Georgeann Couchara sold 952 shares of the stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the sale, the senior vice president now owns 4,212 shares in the company, valued at $1,130,374.44. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 10.90% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. Wells Fargo & Company initiated coverage on shares of Danaher in a research note on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 price target for the company. Barclays decreased their target price on Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 23rd. Robert W. Baird dropped their price target on Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. The Goldman Sachs Group lifted their price objective on Danaher from $225.00 to $250.00 and gave the company a “neutral” rating in a report on Wednesday, July 24th. Finally, Stephens reiterated an “overweight” rating and set a $315.00 target price on shares of Danaher in a report on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $287.16.

Danaher Stock Down 0.2 %

DHR stock opened at $247.18 on Tuesday. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. Danaher Co. has a 52 week low of $192.35 and a 52 week high of $281.70. The stock has a market capitalization of $178.53 billion, a PE ratio of 47.17, a price-to-earnings-growth ratio of 4.55 and a beta of 0.85. The firm has a 50 day moving average of $266.53 and a 200 day moving average of $260.74.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same period in the prior year, the firm earned $2.02 EPS. The firm’s revenue was up 3.1% on a year-over-year basis. Sell-side analysts forecast that Danaher Co. will post 7.51 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were issued a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 annualized dividend and a yield of 0.44%. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.